173 related articles for article (PubMed ID: 37306109)
1. Effect of oestrogen modulation on semen parameters in men with secondary hypogonadism: Systematic review and meta-analysis.
de Silva NL; Dissanayake H; Suarez C; Wickramarachchi RE; Ramasamy R; Dhillo WS; Minhas S; Corona G; Jayasena CN
Andrology; 2024 Feb; 12(2):259-276. PubMed ID: 37306109
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Does hormonal therapy improve sperm retrieval rates in men with non-obstructive azoospermia: a systematic review and meta-analysis.
Tharakan T; Corona G; Foran D; Salonia A; Sofikitis N; Giwercman A; Krausz C; Yap T; Jayasena CN; Minhas S
Hum Reprod Update; 2022 Aug; 28(5):609-628. PubMed ID: 35526153
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?
Awouters M; Vanderschueren D; Antonio L
Andrology; 2020 Nov; 8(6):1590-1597. PubMed ID: 31696669
[TBL] [Abstract][Full Text] [Related]
5. Male-specific consequences of obesity - functional hypogonadism and fertility disorders.
Rabijewski M
Endokrynol Pol; 2023; 74(5):480-489. PubMed ID: 37779374
[TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
Franik S; Eltrop SM; Kremer JA; Kiesel L; Farquhar C
Cochrane Database Syst Rev; 2018 May; 5(5):CD010287. PubMed ID: 29797697
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
Raheem OA; Chen T; Akula KP; Greenberg J; Le TV; Chernobylsky D; Sikka SC; Walsh TJ
Sex Med Rev; 2021 Jul; 9(3):381-392. PubMed ID: 33933392
[TBL] [Abstract][Full Text] [Related]
8. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
[TBL] [Abstract][Full Text] [Related]
9. Novel androgen therapies including selective androgen receptor modulators.
Kang J; Chen R; Tharakan T; Minhas S
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101686. PubMed ID: 35981955
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis.
Tienforti D; Castellini C; Di Giulio F; Totaro M; Dalmazio G; Spagnolo L; Muselli M; Corona G; Baroni MG; Barbonetti A
Andrology; 2023 Sep; 11(6):1067-1076. PubMed ID: 36604313
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants for male subfertility.
Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
[TBL] [Abstract][Full Text] [Related]
12. Hypergonadotropic Hypogonadism: Management of Infertility.
Kalkanli A; Akdere H; Cevik G; Salabas E; Cilesiz NC; Kadioglu A
Curr Pharm Des; 2021; 27(24):2790-2795. PubMed ID: 33138760
[TBL] [Abstract][Full Text] [Related]
13. Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics.
Macdonald AA; Stewart AW; Farquhar CM
Hum Reprod; 2013 Dec; 28(12):3178-87. PubMed ID: 24129611
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility.
Del Giudice F; Busetto GM; De Berardinis E; Sperduti I; Ferro M; Maggi M; Gross MS; Sciarra A; Eisenberg ML
Asian J Androl; 2020; 22(4):360-367. PubMed ID: 31621654
[TBL] [Abstract][Full Text] [Related]
15. Selective oestrogen receptor modulators (SERMs) for endometriosis.
van Hoesel MH; Chen YL; Zheng A; Wan Q; Mourad SM
Cochrane Database Syst Rev; 2021 May; 5(5):CD011169. PubMed ID: 33973648
[TBL] [Abstract][Full Text] [Related]
16. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.
Kim ED; McCullough A; Kaminetsky J
BJU Int; 2016 Apr; 117(4):677-85. PubMed ID: 26496621
[TBL] [Abstract][Full Text] [Related]
17. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
Howell A; Howell SJ; Clarke R; Anderson E
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to Testosterone Therapy: A Review.
Lo EM; Rodriguez KM; Pastuszak AW; Khera M
Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
Franik S; Kremer JA; Nelen WL; Farquhar C
Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men.
Shoshany O; Abhyankar N; Mufarreh N; Daniel G; Niederberger C
Fertil Steril; 2017 Mar; 107(3):589-594. PubMed ID: 28069178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
